Showing 1961-1970 of 8649 results for "".
- Rayner Launches First AI-Designed Spiral IOL, the RayOne Galaxyhttps://modernod.com/news/rayner-announces-launch-of-rayone-galaxy-first-ai-designed-spiral-iol/2482411/Rayner announced its plans to launch the RayOne Galaxy and Galaxy Toric, which the company is calling the world’s first IOL designed with the aid of artificial intelligence. The IOLs will be unveiled at the European Society of Cataract and Refractive Surgeons (
- Orbis Launches AI-Led Diabetic Retinopathy Screening Project in Vietnamhttps://modernod.com/news/orbis-launches-ai-led-diabetic-retinopathy-screening-project-in-vietnam/2482401/Orbis has launched an AI-led diabetic retinopathy (DR) project in Vietnam, aiming to screen 72,000 people with diabetes over the next 3 years. The initiative focuses on providing AI-driven screenings, specialized training for screening teams, and enhancing community awareness of diabeti
- ViaLase Laser Receives CE Mark Approval to Treat Glaucomahttps://modernod.com/news/vialase-laser-receives-ce-mark-approval-to-treat-glaucoma/2482378/ViaLase announced that it has received CE Mark approval in the European Union for the ViaLase laser for the treatment of adult patients with primary open-angle glaucoma. According to the company, the ViaLase laser combines the precision of a femtosecond laser and the accuracy of micron-
- Nicox Announces Recruitment of Last Patient in US in Denali Phase 3 Trial of NCX 470https://modernod.com/news/nicox-announces-recruitment-of-last-patient-in-us-in-denali-phase-3-trial-of-ncx-470/2482375/Nicox announced the recruitment and randomization of the last patient in the United States in its Denali phase 3 trial of NCX 470. The Denali trial is evaluating NCX 470 safety and efficacy in patients with open-angle glaucoma or ocular hypertension. Ac
- iOR Partners Appoints Lance J. Kugler, MD, to the Role of Strategic Advisory Board Chairmanhttps://modernod.com/news/ior-partners-appoints-lance-j-kugler-md-to-the-role-of-strategic-advisory-board-chairman/2482351/Ophthalmic office-based surgery provider IOR Partners announced that Lance J. Kugler, MD, has been named Chairman of the Strategic Advisory Board. Dr. Kugler opened one of the first OBS suites in 2017 and published a study on the safety of office-based lens surgery in The
- Harrow Announces 52-Week Data from Vevye ESSENCE-2 Open-Label Extension Studyhttps://modernod.com/news/harrow-announces-52-week-data-from-vevye-essence-2-open-label-extension-study/2482309/Harrow has announced results from its ESSENCE‑2 open-label extension (OLE) clinical study for Vevye (cyclosporine ophthalmic solution) 0.1%, the first and only cyclosporine to treat the signs and symptoms of dry eye disease (DED). ESSENCE-2 OLE was a phase 3, prospective, multicent
- LambdaVision Closing of Seed Round to Advance Artificial Retina Preclinical Studieshttps://modernod.com/news/lambdavision-closing-of-seed-round-to-advance-artificial-retina-preclinical-studies/2482302/LambdaVision, which is developing a protein-based artificial retina to help patients regain sight lost to retinal degenerative diseases, announced it secured the first closing of its seed round. The proceeds will be used to fund LambdaVision’s GMP manufacturing scale up and critical IN
- Sightpath Medical Acquires LASIK Services Provider PennVistahttps://modernod.com/news/sightpath-medical-acquires-lasik-services-provider-pennvista/2482300/Sightpath Medical, a provider of mobile and fixed ophthalmic surgical services, announced that it has acquired PennVista, a LASIK services business providing equipment and technicians to surgery centers and hospitals in Pennsylvania, Ohio, West Virginia, Indiana, and Michigan. Financial
- Lumibird Launches C.DIAG Dry Eye Diagnostic Aid Platformhttps://modernod.com/news/lumibird-launches-cdiag-dry-eye-diagnostic-aid-platform-platform/2482260/Lumibird Medical announced the launch of the C.DIAG, a new-generation dry eye diagnostic aid platform with integrated AI algorithms. This new component of the C.SUITE is designed to enable healthcare professionals to diagnose, treat and educate dry eye patients. &ldq
- Sight Sciences Announces the Publication of Large-Scale, Real-World MIGS Study Demonstrating Aqueous Outflow Restorative Procedure with OMNIhttps://modernod.com/news/sight-sciences-announces-the-publication-of-large-scale-real-world-migs-study-demonstrating-aqueous-outflow-restorative-procedure-with-omni/2482226/Sight Sciences announced the results as published in the American Journal of Ophthalmology (AJO) International of a large scale, comparative real-world clinical outcomes study of patients treated by three leading, minimally invasive glaucoma surgery (MIGS) technologies.